Digital health fails on trust and distribution, not features
The product is rarely the hard part. The hard part is the first thousand patients who have no reason to trust a screen, the last mile where the service has to physically arrive, the cash-pay economics that most Western playbooks never had to solve, and the clinical operation underneath that has to run on data before anything above it can. The trust cold-start in two-sided health platforms is where most of my work begins.
- Product strategy and go-to-market for health-tech. Positioning, pricing, channel and launch for telehealth, diagnostics, pharmacy and platform businesses, built for the market you are actually in.
- Platform adoption and the trust cold-start. How a two-sided health platform gets its first patients and its first providers to believe it, and what to measure while it does.
- Clinical-operations digitization. ERP and BI inside a clinical group so that retention, throughput and cost are managed on numbers, the way Laser Treat Group's were.
- Cash-pay and low-insurance markets. When patients pay cash, everything about the product changes: the discipline Bangladesh forces and US digital health is now learning.
- Service design under constraint. A first-in-country traveller-testing service with a six-hour turnaround and a government portal integration, built during lockdowns.
Proof, not promises
Three engagements that show the pattern. Each one opens the full case study.
Bangladesh already made the leapfrog
Diagnostics-led care, telehealth that comes to the patient, pharmacy as the front door, cash-pay economics: Bangladesh built these out of necessity while the United States was still debating reimbursement codes. The health-tech leapfrog Bangladesh already made is a playbook, and I operated inside it. For a US health-tech company, that is a set of proven answers to problems you are only now meeting. For a Bangladeshi one, it is a strategist who can translate the model to a US buyer, regulator and investor.
Who this is for, and who it is not
It is for health-tech founders from seed to Series B, hospital and clinical groups digitizing their operations, telehealth, diagnostics and pharmacy platforms, and investors who need an operator's read on a health-tech business, in Bangladesh and the United States. It is not for software engineering; I work with your product and engineering leads on what to build and why, not on how.
Start with a thirty-minute call
Bring the number you are trying to move. I will tell you what I would look at first, and whether I am the right person to look at it.
Questions people ask before we talk
Is this product strategy or growth?
Both, because in digital health they are the same problem. A product patients do not trust does not grow, and growth built on a clinical operation that does not run on data does not last.
Do you work with early-stage companies?
Yes, from the point where there is a service and a first cohort of patients or providers. The trust cold-start is where early-stage health platforms most often stall.
Do you work with hospital groups?
Yes. I directed growth for a hospital brand and ran a multi-entity clinical group as chief operating officer, including the ERP and BI digitization.
Do you work in both Bangladesh and the United States?
Yes. The operating record is from Bangladesh; I am based in Michigan and work with US health-tech companies, and with Bangladeshi companies entering the US.
What does the first month look like?
A product-and-growth diagnosis: your unit economics, your funnel, ten patient and provider conversations, and a written read on the single constraint most likely to be holding adoption back.
Md Shafaat Ali Choyon (also written Shafaat Choyon) is a digital health, growth and public-health strategist based in Redford, Michigan. MBA, MCIM, MPH and CHES®. Founder of HSREP, a health-system resilience platform. The same body of work, presented for other needs: growth marketing, Michigan, growth marketing, Bangladesh, fractional CMO, Michigan, brand and communications, health communication, population health, fractional COO and CMO, health. Bangladesh readers: বাংলায় পড়ুন.